SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001437749-23-013985
Filing Date
2023-05-11
Accepted
2023-05-11 17:04:28
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 425 dffn20230511_425.htm 425 22520
2 EXHIBIT 99.1 ex_519407.htm EX-99.1 12463
3 eip.jpg GRAPHIC 17818
  Complete submission text file 0001437749-23-013985.txt   61708
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filed by) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Subject) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-37942 | Film No.: 23912075
SIC: 2834 Pharmaceutical Preparations